single-source suppliers
“10-K Item 1A: 'We maintain several single-source supplier relationships, either because alternative sources are not available or because the relationship is advantageous'”
Updated
The most significant concentration Perrigo Company discloses is single-source suppliers, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Perrigo Company’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
“10-K Item 1A: 'We maintain several single-source supplier relationships, either because alternative sources are not available or because the relationship is advantageous'”
“10-K Item 1: 'Our top ten customers accounted for 47% of our total consolidated net sales in 2025 and 2024.'”
“10-K Item 1: 'Sales to Walmart Inc. represented 12.9% and 11.9% of our consolidated net sales in 2025 and 2024, respectively.'”
Perrigo's concentration risk sits mostly on the supply side. The company maintains several single-source supplier relationships, either because no alternative source exists or because the relationship is otherwise advantageous — a high-share dependency exposure with no diversification cushion if one of those relationships is disrupted. On the customer side, the top ten customers accounted for 47% of consolidated net sales in both 2025 and 2024, a medium-share dependency, while within that group Walmart Inc. alone represented 12.9% of consolidated net sales in 2025, up from 11.9% in 2024 — a low-share exposure. These two exposures net out differently. The single-source supplier dependence is the more consequential of the two because it is undiversified by construction — any disruption at one of those suppliers has no immediate substitute — whereas the customer-side concentration is spread across ten accounts, with the largest single name, Walmart, contributing only a low-share slice of sales. The customer concentration is therefore more diversification-tolerant than the supply-side exposure, which is the one line most capable of moving the verdict on its own.
For the engine’s reasoning on PRGO’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| ANIP | ANI Pharmaceuticals, Inc. | 2 | 1 | 0 | 3 |
| AMLX | Amylyx Pharmaceuticals, Inc. | 2 | 0 | 0 | 2 |
| AMPH | Amphastar Pharmaceuticals, Inc. | 1 | 2 | 1 | 4 |
| PRGO● | Perrigo Company plc | 1 | 1 | 1 | 3 |
| AMRX | Amneal Pharmaceuticals, Inc. | 1 | 1 | 0 | 2 |
| ALKS | Alkermes plc | 0 | 1 | 1 | 2 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.